Newport Cigarettes: What the Research Actually Shows
Newport Cigarettes: What the Research Actually Shows
Newport is the best-selling menthol cigarette in the United States, and studies consistently show menthol smokers face a harder quit. If you smoke Newports, that’s not in your head.
This page pulls together what the science actually says about menthol, nicotine delivery, and the quit process for Newport smokers specifically. No fluff, just the data.
Why Menthol Makes Quitting Harder
Menthol activates cold-sensing receptors in your airways (TRPM8), which numbs the throat irritation that normally signals “this is damaging you.” That smoothness isn’t neutral. It lets you inhale deeper and more often, increasing nicotine exposure per cigarette.
A 2013 FDA analysis found that menthol cigarette smokers show greater nicotine dependence scores than non-menthol smokers at equivalent smoking rates. They also had lower quit rates in most population studies reviewed. The biological mechanism is real.
Menthol also interacts with nicotinic acetylcholine receptors directly, enhancing the rewarding effects of nicotine. This is separate from the airway-smoothing effect. Two distinct reinforcement pathways instead of one.
Newport’s Market Position and Who Smokes Them
Newport is made by Reynolds American (now a subsidiary of British American Tobacco, which completed its $49 billion acquisition of Reynolds in 2017). Newport was originally a Lorillard brand until Reynolds paid $27.4 billion to acquire Lorillard in 2015.
The brand holds roughly 14% of the total U.S. cigarette market and commands about 35% of the menthol segment. That’s not an accident. Decades of targeted marketing into urban communities drove those numbers.
CDC data shows approximately 85% of Black adult smokers use menthol cigarettes, compared to about 29% of white adult smokers. The Truth Tobacco Industry Documents project, which publishes internal tobacco company records, includes extensive internal Lorillard strategy memos explicitly targeting Black consumers and youth in urban markets going back to the 1970s. Researchers Valerie Yerger and Ruth Malone published a detailed analysis of these documents in the American Journal of Public Health in 2005, documenting the systematic nature of that targeting.
What Each Newport Cigarette Delivers
Newport 100s and King Size deliver roughly 1.3 to 1.7 mg of nicotine per cigarette under machine-measured conditions. Real-world intake is higher because menthol smokers tend to inhale more deeply and block filter vents.
They also contain additives beyond menthol: acetaldehyde (which synergizes with nicotine to increase addiction), ammonia compounds (which raise pH and speed nicotine absorption), and various flavor additives. The full ingredient list was disclosed through litigation and is available through the Massachusetts Department of Public Health’s tobacco manufacturer disclosure database.
Each pack of 20 puts roughly 25-35 mg of nicotine into your system, depending on your smoking pattern.
The FDA Menthol Ban: Where It Stands
The FDA issued a proposed rule to ban menthol cigarettes in April 2022. As of early 2026, that rule remains blocked by ongoing litigation from tobacco manufacturers and has not taken effect. The FDA’s own modeling estimated a menthol ban would lead 923,000 smokers to quit within 40 years, with a disproportionate impact on Black and youth smokers.
This matters practically: Newport is still legal to buy, still being marketed, and the regulatory landscape has not changed what’s on the shelf at your corner store.
Real Quit Experiences from Newport Smokers
Marcus, 34, from Baltimore, smoked Newport 100s for 11 years before quitting in 2023. “The first thing that actually helped was the nicotine patch at the 21mg dose. I’d tried cold turkey twice. Menthols are different, they go down too easy so your brain doesn’t get the warning signal that regular cigarettes give some people.” He credits combining the patch with a quit smoking app that tracked his cravings by time of day as the combination that finally broke the habit.
Latasha, 29, from Atlanta, describes Newport as “the social cigarette” in her circle. She switched to nicotine lozenges and used them aggressively for six months. “I needed something I could pop before going out where everyone was smoking. The lozenge got me through those situations.”
Both described the physical throat sensation from menthol as something they missed in a way that felt distinct from just craving nicotine. That’s consistent with the TRPM8 research: menthol trains a sensory expectation that NRT doesn’t replicate.
NRT Options That Work for Menthol Smokers
Menthol-flavored NRT exists specifically because quitting menthol cigarettes involves breaking two habits at once: nicotine dependence and the menthol airway sensation.
| NRT Option | Menthol Version Available | Best For |
|---|---|---|
| Nicotine patch | No | Background craving control |
| Nicotine gum | Yes (Nicorette mint) | Oral fixation, situational cravings |
| Nicotine lozenge | Yes (mint flavor) | Social situations, post-meal cravings |
| Nicotine inhaler | No (but mimics hand-to-mouth) | Behavioral habit replacement |
| Varenicline (Rx) | N/A | High-dependence smokers, any cigarette type |
Combination therapy (patch plus a fast-acting option like gum or lozenge) outperforms single NRT in clinical trials. The Cochrane Review on NRT combination therapy found it increases quit rates by about 34% compared to single NRT.
If budget is a constraint, there are effective options under $10 that can bridge you through the acute craving phase.
Key Studies and Sources
These are the primary research documents cited above, accessible publicly:
- FDA Menthol Report (2013): Menthol in Cigarettes, Tobacco Products: Request for Comments and Scientific Evidence - FDA.gov
- Yerger & Malone (2005): “African American Leadership Groups: Smoking With the Enemy” - American Journal of Public Health, 95(3)
- Tobacco Industry Documents: Available at industrydocuments.ucsf.edu - search “Lorillard Newport urban”
- Massachusetts Tobacco Disclosure Database: mass.gov/tobacco-manufacturer-disclosure
- Cochrane NRT Review: Hartmann-Boyce et al., “Nicotine replacement therapy versus control for smoking cessation” - Cochrane Database, updated 2018
Bottom Line for Newport Smokers
Quitting Newports is harder than quitting non-menthol cigarettes on average. That’s not a personal weakness. It’s pharmacology. Knowing that changes how you approach the quit: higher-dose NRT, combination therapy, and planning specifically for the menthol craving alongside the nicotine craving.
The best quit smoking apps can help you track craving patterns that are specific to your smoking routine, which matters more for high-frequency smokers like most Newport users.
You’re not fighting just one thing. Treat it accordingly.